标题
Immune correlates of vaccine protection against HIV-1 acquisition
作者
关键词
-
出版物
Science Translational Medicine
Volume 7, Issue 310, Pages 310rv7-310rv7
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2015-10-22
DOI
10.1126/scitranslmed.aac7732
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COMPASS identifies T-cell subsets correlated with clinical outcomes
- (2015) Lin Lin et al. NATURE BIOTECHNOLOGY
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
- (2015) J. G. Jardine et al. SCIENCE
- Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein
- (2015) J. Chen et al. SCIENCE
- HIV-1 neutralizing antibodies induced by native-like envelope trimers
- (2015) R. W. Sanders et al. SCIENCE
- Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys
- (2015) D. H. Barouch et al. SCIENCE
- Infection of monkeys by simian-human immunodeficiency viruses with transmitted/founder clade C HIV-1 envelopes
- (2015) Mohammed Asmal et al. VIROLOGY
- Fcγ Receptor Variability in the South African Population - Will this Impact HVTN097 Vaccine Efficacy?
- (2014) Ria Lassauniere et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Ten years after Dublin: principal trends in HIV surveillance in the EU/EEA, 2004 to 2013
- (2014) A Pharris et al. Eurosurveillance
- Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved
- (2014) Kevin Wiehe et al. IMMUNITY
- FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
- (2014) Shuying S. Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Live Simian Immunodeficiency Virus Vaccine Correlate of Protection: Immune Complex–Inhibitory Fc Receptor Interactions That Reduce Target Cell Availability
- (2014) Anthony J. Smith et al. JOURNAL OF IMMUNOLOGY
- HIV-1 Vaccine-Induced C1 and V2 Env-Specific Antibodies Synergize for Increased Antiviral Activities
- (2014) Justin Pollara et al. JOURNAL OF VIROLOGY
- Generation and Evaluation of Clade C Simian-Human Immunodeficiency Virus Challenge Stocks
- (2014) Hui-Wen Chang et al. JOURNAL OF VIROLOGY
- Enhanced neonatal Fc receptor function improves protection against primate SHIV infection
- (2014) Sung-Youl Ko et al. NATURE
- Ending AIDS — Is an HIV Vaccine Necessary?
- (2014) Anthony S. Fauci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
- (2014) Susan Zolla-Pazner et al. PLoS One
- Antibody persistence and T-cell balance: Two key factors confronting HIV vaccine development
- (2014) G. K. Lewis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Host Controls of HIV Neutralizing Antibodies
- (2014) B. F. Haynes et al. SCIENCE
- Polyfunctional Fc-Effector Profiles Mediated by IgG Subclass Selection Distinguish RV144 and VAX003 Vaccines
- (2014) A. W. Chung et al. Science Translational Medicine
- Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
- (2014) A. Pegu et al. Science Translational Medicine
- Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
- (2014) N. L. Yates et al. Science Translational Medicine
- Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
- (2014) Susan Zolla-Pazner et al. EBioMedicine
- Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys
- (2013) Dan H. Barouch et al. CELL
- Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
- (2013) Hua-Xin Liao et al. IMMUNITY
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
- (2013) Raphael Gottardo et al. PLoS One
- Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
- (2013) G. D. Tomaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
- (2013) F. Tanser et al. SCIENCE
- Nonreplicating vectors in HIV vaccines
- (2013) Jennifer A. Johnson et al. Current Opinion in HIV and AIDS
- The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
- (2012) Nicos Karasavvas et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
- (2012) D. C. Montefiori et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
- (2012) M. Bonsignori et al. JOURNAL OF VIROLOGY
- Antigenicity and Immunogenicity of RV144 Vaccine AIDSVAX Clade E Envelope Immunogen Is Enhanced by a gp120 N-Terminal Deletion
- (2012) S. Munir Alam et al. JOURNAL OF VIROLOGY
- Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
- (2012) Morgane Rolland et al. NATURE
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
- (2012) Dan H. Barouch et al. NATURE
- Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
- (2012) Barton F. Haynes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA
- (2011) S. Zolla-Pazner et al. JOURNAL OF VIROLOGY
- Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
- (2011) Y. Li et al. JOURNAL OF VIROLOGY
- HIV Vaccine Development — Improving on Natural Immunity
- (2011) Margaret I. Johnston et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV-1 Vaccines and Adaptive Trial Designs
- (2011) L. Corey et al. Science Translational Medicine
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- Poxvirus vector-based HIV vaccines
- (2010) Giuseppe Pantaleo et al. Current Opinion in HIV and AIDS
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV-1-specific antibody responses during acute and chronic HIV-1 infection
- (2009) Georgia D Tomaras et al. Current Opinion in HIV and AIDS
- HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
- (2008) M Juliana McElrath et al. LANCET
- EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
- (2008) Pierre-Alexandre Bart et al. VACCINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now